LSB LakeShore Biopharma Co., Ltd.

Nasdaq www.ysbiopharma.com


$ 0.49 $ -0.16 (-20.68 %)    

Friday, 19-Sep-2025 19:37:19 EDT
QQQ $ 603.49 $ -7.34 (-1.2 %)
DIA $ 466.57 $ -2.65 (-0.56 %)
SPY $ 666.57 $ -5.27 (-0.78 %)
TLT $ 92.12 $ 0.13 (0.14 %)
GLD $ 372.17 $ -0.70 (-0.19 %)
$ 0.627
$ 0.79
$ 0.29 x 200
$ 0.63 x 10,000
-- - --
$ 0.57 - $ 8.60
942,216
na
11.93M
$ 0.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

LakeShore Biopharma Co., Ltd (NASDAQ:LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical ...

Core News & Articles

LakeShore Biopharma Co., Ltd (NASDAQ:LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical ...

 why-aes-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket

Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover...

Core News & Articles

Revolutionizing Vaccination Safety with Needle-Free Reconstitution TechnologyBEIJING, April 23, 2025 /PRNewswire/ -- On April 1...

Core News & Articles

FY2025 Guidance UpdateFor the full FY2025, the Company expects total revenues to be between RMB 665 million and RMB 700 million...

Core News & Articles

Investigation Details: The Company has uncovered evidence suggesting that Yi Zhang, during his tenure in key executive roles, m...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION